For six long years, my children suffered from frightening psychiatric symptoms that resisted treatment. When a surprising ...

Provides broad overview of Company's research and early development programs expected to continue to fuel future growth ...

Provides broad overview of Company's research and early development programs expected to continue to fuel future growthHighlights validation of T-cell engager modality with mRNA-2808 in multiple myelo ...

Businesses with 15+ employees must provide accommodations under the ADA. Simple, often free changes improve morale and ...

New analyses from the Phase 3 Vivacity-MG3 study support the impact of nipocalimab in anti-AChR+a, anti-MuSK+b adult patients with generalised myasthenia gravis (gMG) including those early in their ...

(NASDAQ: LONA), a clinical-stage biopharmaceutical company dedicated to the development of novel therapeutics for diseases with high unmet medical needs, today announced that Javier San Martin, MD, ...

By: Tomos Land, Staff Writer Kind of a Big Deal, a short animated documentary recently released by the Knowledge Network, ...

Multiple sclerosis (MS) can have a substantial impact on many aspects of life beyond physical health, with 51% of people ...

Why does multiple sclerosis progress quickly in some people, while others remain stable for years? Researchers from the ...

Multiple sclerosis (MS) can have a substantial impact on many aspects of life beyond physical health, with 51% of people ...

Credit: Getty Images Researchers discuss the potential neurologic effects of the menopausal transition on cognitive decline and multiple sclerosis progression. Menopause is increasingly recognized as ...

Researchers have identified two compounds, K102 and K110, that could repair the nerve damage from multiple sclerosis. These drugs help regenerate the protective myelin sheath and balance immune ...